Author Archives: clinicalaccelerator

AtriAN Medical’s Clinical Data Highlighted at the 2022 AF Symposium

Pioneering cardiac autonomic pulsed field ablation (PFA) technology provides a unique option for enhancing the durability of AF ablation. GALWAY, Ireland, Jan. 17, 2022 /PRNewswire/ — Irish medical device company AtriAN Medical today announced that clinical data from it’s first-in-human study was presented … Continue reading

Posted in Cardiology, Clinical Accelerator, Conferences, Medical Devices | Leave a comment

Cardiovascular Systems, Inc. Announces First In-Human Experience With Coronary Everolimus Drug Coated Balloon

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the start of enrollment in a first in-human trial of the coronary everolimus … Continue reading

Posted in Uncategorized | Leave a comment

Restore Medical Announces First in Human Trial for Treatment of Heart Failure in Patients

ContraBand™ technology helps restore the heart’s functionality and may significantly improve patients’ quality of life OR YEHUDA, Israel, Dec. 7, 2021 /PRNewswire/ — Restore Medical Ltd., a clinical-stage MedTech company developing cardiac implants for the treatment of congestive heart failure (CHF), today announced promising … Continue reading

Posted in Uncategorized | Leave a comment

Congress CSI Focus D-HF, Frankfurt, Germany, December 10-11th 2021

Clinical Accelerator is proud to have sponsored the CSI Focus D-HF (Device therapies in heart failure) conference this year in Frankfurt, Germany. Organized by Dr Horst Sievert, the two-day conference was one of the first to be in person in … Continue reading

Posted in Uncategorized | Leave a comment

Anteris Technologies CEO talks ‘outstanding results’ from first human DurAVR patients

Anteris Technologies CEO talks ‘outstanding results’ from first human DurAVR patients

Posted in Uncategorized | Leave a comment

Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients

June 1, 2021 8:03 AM DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) has acquired preCARDIA, developer of a proprietary catheter and controller that will complement Abiomed’s product portfolio to expand options for patients with acute decompensated heart failure (ADHF). The preCARDIA system is … Continue reading

Posted in Cardiology, Medical Devices | Leave a comment

Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences

Minimally-invasive, implant-free technology for heart failure patients studied at 1 and 3 months May 17, 2021 09:36 AM Eastern Daylight Time AUSTIN, Texas–(BUSINESS WIRE)–Alleviant Medical Inc., a privately-held medical device company, today announced one-month and three-month follow up data from … Continue reading

Posted in Cardiology, Medical Devices | Leave a comment

Clinical Accelerator announces collaboration with InterVene for developing an endovascular device for deep vein valve failure

Clinical Accelerator is pleased to announce that is has begun a collaboration with InterVene, to run an early human feasibility study (EHFS) on their novel endovascular device – BlueLeaf Endovenous Valve Formation System – for deep vein valve failure. Currently, … Continue reading

Posted in Cardiology, Clinical Accelerator, Medical Devices | Leave a comment

Positive Preliminary Clinical Trial Results Reported for Vascular Dynamics’ Novel Heart Failure Treatment Technology

Endovascular baroreflex modulation data presented Feb 9, 2021 IRVINE, CALIF – (February 9, 2021) – Vascular Dynamics, Inc., a privately held medical device company focused on innovative, endovascular device-based solutions for cardiovascular conditions, has announced positive preliminary results from its … Continue reading

Posted in Cardiology, Central and Eastern Europe, Medical Devices | Leave a comment

Clinical Accelerator collaborates with Metavention on a study of a novel medical device for hypertension

Clinical Accelerator and Metavention have recently entered into a collaboration allowing Clinical Accelerator to join the program of feasibility studies already under way in the United States, New Zealand and Australia. Our organization will participate in the renal denervation trial … Continue reading

Posted in Cardiology, Central and Eastern Europe, Clinical Accelerator, Medical Devices | Tagged , , , | Leave a comment